Table 2 Demographic and clinical information of the SOT recipients in the Pre- and Post-ASP (N = 2791)
Demographic information | Pre ASP intervention N = 1154 (%) | Post ASP intervention N = 1637 (%) | p -value |
|---|---|---|---|
Age | 55.01 ± 13.81 | 56.00 ± 14.01 | 0.77 |
Sex | |||
Male | 671 (58.14%) | 692 (42.27%) | 0.52 |
Female | 483 (41.85%) | 945 (57.72%) | |
Comorbidities | |||
DM | 504 (43.67%) | 609 (37.2%) | 0.76 |
HTN | 498 (43.15%) | 557 (34.02%) | 0.92 |
Cardiovascular disease | 610 (52.85%) | 595 (36.34%) | 0.61 |
COPD or Asthma | 102 (8.83%) | 68 (4.15%) | 0.70 |
DVT or PTE | 41 (3.55%) | 33 (2.01%) | 0.14 |
ESRD | 298 (25.82%) | 434 (26.51%) | 0.09 |
Liver cirrhosis | 167 (14.47%) | 491 (29.99%) | 0.11 |
Transplantation status transplanted | 689 (59.7%) | 702 (42.88%) | 0.08 |
Candidate for transplantation | 465 (40.29%) | 935 (57.11%) | |
Type of SOT | |||
Liver | 305 (44.26%) | 339 (48.29%) | 0.90 |
Kidney | 352 (51.08%) | 325 (64.29%) | 0.07 |
MVT | 9 (1.3%) | 3 (0.42%) | 0.10 |
SPK | 14 (2.03%) | 21 (2.99%) | 0.85 |
Small bowel | 5 (0.72%) | 3 (0.42%) | 0.13 |
Heart and lung | 4 (0.58%) | 11 (1.56%) | 0.06 |
Time since transplantation(months) | 53 ± 11.09 | 57.08 ± 10.98 | 0.48 |
Intensive care units’ admissions(n) | 670 | 701 | 0.85 |